Novo Holdings A/S Long-Term Concentrated

Location: Hellerup, Denmark

CIK: 0001388325 · Show all filings

Period: Q2 2024 (← Previous) (Next →)

Filing Date: Aug 20, 2024

Total Value: $1.855B (100.0% shares, 0.0% debt)

Holdings (38)

VTI VANGUARD INDEX FDS 15.0%
Value $278M Shares 1,038,550 Est. Cost $267.51 Unrealized
BN BROOKFIELD CORP 8.7%
Value $161M Shares 3,880,230 Est. Cost $22.16 Unrealized +24.4%
TEM TEMPUS AI INC 7.7%
Value $143M Shares 4,074,419 Est. Cost $30.66 Unrealized 0.0%
ASML ASML HOLDING N V 7.4%
Value $136M Shares 133,336 Est. Cost $654.82 Unrealized
CRM SALESFORCE INC 6.7%
Value $123M Shares 480,160 Est. Cost $193.03 Unrealized +37.1%
EWTX EDGEWISE THERAPEUTICS INC 6.2%
Value $114M Shares 6,344,430 Est. Cost $17.44 Unrealized 0.0%
CORT CORCEPT THERAPEUTICS INC 4.2%
Value $78.35M Shares 2,411,362 Est. Cost $23.02 Unrealized +19.0%
PCVX VAXCYTE INC 3.9%
Value $71.73M Shares 950,000 Est. Cost $31.07 Unrealized +119.1%
INSM INSMED INC 2.9%
Value $53.6M Shares 800,000 Est. Cost $23.10 Unrealized +67.9%
MIRM MIRUM PHARMACEUTICALS INC 2.8%
Value $51.28M Shares 1,500,000 Est. Cost $12.27 Unrealized +113.7%
CRNX CRINETICS PHARMACEUTICALS IN 2.4%
Value $44.79M Shares 1,000,000 Est. Cost $19.36 Unrealized +138.5%
CABO CABLE ONE INC 2.3%
Value $41.91M Shares 118,403 Est. Cost $987.67 Unrealized -62.4%
BMRN BIOMARIN PHARMACEUTICAL INC 2.2%
Value $40.34M Shares 490,000 Est. Cost $84.22 Unrealized -1.2%
MERUS N V 2.2%
Value $39.94M Shares 675,000 Est. Cost $59.17 Unrealized
AAPL APPLE INC 2.1%
Value $38.54M Shares 182,960 Est. Cost $90.57 Unrealized +104.4%
BABA ALIBABA GROUP HLDG LTD 1.9%
Value $36.06M Shares 500,827 Est. Cost $165.09 Unrealized
PHVS PHARVARIS N V 1.7%
Value $32.43M Shares 1,725,000 Est. Cost $15.26 Unrealized +33.3%
CLDX CELLDEX THERAPEUTICS INC NEW 1.7%
Value $31.46M Shares 850,000 Est. Cost $37.73 Unrealized 0.0%
FDMT 4D MOLECULAR THERAPEUTICS IN 1.6%
Value $29.39M Shares 1,400,000 Est. Cost $17.62 Unrealized +42.4%
LANZATECH GLOBAL INC 1.6%
Value $29.26M Shares 15,814,845 Est. Cost $3.88 Unrealized
ALNY ALNYLAM PHARMACEUTICALS INC 1.6%
Value $28.77M Shares 118,383 Est. Cost $160.04 Unrealized -1.4%
AVBP ARRIVENT BIOPHARMA INC 1.5%
Value $27.82M Shares 1,500,000 Est. Cost $19.51 Unrealized -8.6%
VRDN VIRIDIAN THERAPEUTICS INC 1.4%
Value $26.02M Shares 2,000,000 Est. Cost $16.89 Unrealized -18.0%
CARGO THERAPEUTICS INC 1.4%
Value $25.35M Shares 1,544,000 Est. Cost $21.87 Unrealized
FOLD AMICUS THERAPEUTICS INC 1.3%
Value $24.8M Shares 2,500,000 Est. Cost $12.83 Unrealized -20.0%
BAM BROOKFIELD ASSET MANAGMT LTD 1.3%
Value $23.87M Shares 627,207 Est. Cost $31.11 Unrealized +19.7%
RCKT ROCKET PHARMACEUTICALS INC 1.3%
Value $23.68M Shares 1,100,000 Est. Cost $28.09 Unrealized -18.2%
LXEO LEXEO THERAPEUTICS INC 1.3%
Value $23.27M Shares 1,450,500 Est. Cost $13.07 Unrealized +11.1%
BLUEPRINT MEDICINES CORP 1.0%
Value $18.86M Shares 175,000 Est. Cost $59.75 Unrealized
KYTX KYVERNA THERAPEUTICS INC 0.7%
Value $13.13M Shares 1,750,000 Est. Cost $20.30 Unrealized -24.7%
MORPHIC HLDG INC 0.7%
Value $12.78M Shares 375,000 Est. Cost $34.07 Unrealized
VERVE THERAPEUTICS INC 0.6%
Value $11.71M Shares 2,400,000 Est. Cost $12.43 Unrealized
MGX METAGENOMI INC 0.4%
Value $7.344M Shares 1,800,000 Est. Cost $11.34 Unrealized -39.4%
IOBT IO BIOTECH INC 0.3%
Value $5.182M Shares 4,429,449 Est. Cost $6.26 Unrealized -77.7%
ABCL ABCELLERA BIOLOGICS INC 0.2%
Value $3.336M Shares 1,126,915 Est. Cost $8.47 Unrealized -55.3%
MQ MARQETA INC 0.1%
Value $2.42M Shares 441,558 Est. Cost $22.37 Unrealized -75.4%
GALECTO INC 0.1%
Value $1.184M Shares 2,497,791 Est. Cost $12.51 Unrealized
SPRO SPERO THERAPEUTICS INC 0.0%
Value $610K Shares 468,902 Est. Cost $11.41 Unrealized -86.8%